Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non–Small Cell Lung Cancer: A Phase II Clinical Trial-Reference-Cited by-同舟云学术

Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non–Small Cell Lung Cancer: A Phase II Clinical Trial

Published:2017-06 Issue:6 Volume:12 Page:983-992
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Sun Bing,Brooks Eric D.,Komaki Ritsuko,Liao Zhongxing,Jeter Melenda,McAleer Mary,Balter Peter A.,Welsh James D.,O’Reilly Michael,Gomez Daniel,Hahn Stephen M.,Sepesi Boris,Rice David C.,Heymach John V.,Chang Joe Y.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference31 articles.

1. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

2. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis;Senthi;Lancet Oncol,2012

3. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410;Curran;J Natl Cancer Inst,2011

4. Postoperative oligo-recurrence of non-small-cell lung cancer: clinical features and survival;Hishida;Eur J Cardiothorac Surg,2016

5. Second lung cancers in patients after treatment for an initial lung cancer;Johnson;J Natl Cancer Inst,1998

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STRILL: Phase I Trial Evaluating Stereotactic Body Radiotherapy (SBRT) Dose Escalation for Re-Irradiation of Inoperable Peripheral Lung Lesions;Diseases;2024-07-12

2. The relationship between splenic dose and radiation-induced lymphopenia;Journal of Radiation Research;2024-05

3. Novel prognostic signature for lung adenocarcinoma based on immune-related mRNA pairs;Heliyon;2024-02

4. Radiotherapy in the management of lung oligometastases;Cancer/Radiothérapie;2024-02

5. Prognosis of patients with recurrent nonsmall cell lung cancer who received the best supportive care alone;Current Problems in Surgery;2024-01